Insider sale
LANTERN PHARMA INC.
$97.3K
29.58K shares
What this filing means
BIOS FUND I QP, LP plans to sell 29.58K shares of LANTERN PHARMA INC. valued at approximately $97.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/27/2025ACC: 0001104659-25-053174
29.58K
Shares to sell
$97.3K
Approx. market value
329.90K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Conversion of Shares in IPO
Conversion
6/15/2020
329.90KTotal acquired329.90K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/15/2020 | Conversion of Shares in IPO Conversion | 329.90K | — |
| Total | 329.90K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
29.58K
Market value
$97.3K
5/27/2025
Total
Units
29.58K
Value
$97.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/27/2025 | 29.58K | $97.3K | NASDAQ | Planned |
| Total | 29.58K | $97.3K | ||